Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
28-Aug-2023
Nyrada Full Year Results FY2023
28-Aug-2023
Annual Report for year ended 30 June 2023
28-Aug-2023
Preliminary Final Report
28-Aug-2023
Appendix 4G and Corporate Governance Statement
28-Jul-2023
Quarterly Activities Report and Appendix 4C
20-Jul-2023
Nyrada Review of Operating Costs
26-Jun-2023
Cholesterol-Lowering Program Update
9-Jun-2023
Brain Injury Program Preclinical Development Update
26-May-2023
Cholesterol-Lowering Program Preclinical Studies Completed
26-Apr-2023
Quarterly Activities Report and Appendix 4C
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Next
